| Price | 58.00p on 23-12-2025 at 16:13:25 |
|---|---|
| Change | -3.00p -4.92% |
| Buy | 59.00p |
| Sell | 57.00p |
| Last Trade: | Sell 15,000.00 at 57.266p |
| Day's Volume: | 1,684,806 |
| Last Close: | 61.00p |
| Open: | 61.00p |
| ISIN: | GB00BYYW9G87 |
| Day's Range | 58.00p - 61.50p |
| 52wk Range: | 27.25p - 83.20p |
| Market Capitalisation: | £251.52m |
| VWAP: | 60.1057p |
| Shares in Issue: | 433.66m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Avacta Group (AVCT) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 15,000 | 57.266p | Ordinary |
16:13:23 - 23-Dec-25 |
| Sell* | 11,700 | 57.88p | Ordinary |
16:13:04 - 23-Dec-25 |
| Sell* | 10,000 | 57.266p | Ordinary |
16:12:46 - 23-Dec-25 |
| Sell* | 853 | 57.88p | Ordinary |
16:12:40 - 23-Dec-25 |
| Sell* | 20,000 | 58.00p | Ordinary |
16:12:20 - 23-Dec-25 |
| Sell* | 10,000 | 58.04p | Ordinary |
16:11:49 - 23-Dec-25 |
| Sell* | 3,000 | 58.04p | Ordinary |
16:08:45 - 23-Dec-25 |
| Sell* | 27,154 | 58.00p | Ordinary |
16:08:42 - 23-Dec-25 |
| Sell* | 175 | 58.88p | Ordinary |
16:07:08 - 23-Dec-25 |
| Sell* | 10,000 | 58.00p | Ordinary |
16:05:29 - 23-Dec-25 |
Avacta Group (AVCT) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 18th Dec 2025 7:00 am | RNS-R | Avacta reports new AVA6103 pharmacology data |
| 17th Dec 2025 7:00 am | RNS | Faridoxorubicin Phase 1b SGC data |
| 8th Dec 2025 7:00 am | RNS | Preliminary Data in Faridoxorubicin Phase 1b Trial |
| 3rd Nov 2025 8:24 am | RNS | Completion of Placing and TVR |
| 27th Oct 2025 5:39 pm | RNS | Block Listing Six Monthly Return |
| 27th Oct 2025 7:00 am | RNS | Avacta presents preclinical data at AACR-NCI-EORTC |
| 23rd Oct 2025 5:00 pm | RNS-R | Notice of Investor Presentation |
| 20th Oct 2025 7:01 am | RNS | Equity fundraise of £16 million |
| 20th Oct 2025 7:00 am | RNS | Avacta Presents Phase 1a Data for Faridoxorubicin |
| 13th Oct 2025 7:00 am | RNS | Avacta to present data at EORTC-NCI-AACR |
